Logo image of SSKN

STRATA SKIN SCIENCES INC (SSKN) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:SSKN - US86272A3059 - Common Stock

1.39 USD
-0.06 (-4.14%)
Last: 12/2/2025, 8:08:32 PM
1.3519 USD
-0.04 (-2.74%)
After Hours: 12/2/2025, 8:08:32 PM

SSKN Key Statistics, Chart & Performance

Key Statistics
Market Cap8.19M
Revenue(TTM)33.56M
Net Income(TTM)-11.54M
Shares5.89M
Float4.07M
52 Week High3.86
52 Week Low1.24
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-2.67
PEN/A
Fwd PEN/A
Earnings (Next)03-25 2026-03-25/amc
IPO2005-10-28
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


SSKN short term performance overview.The bars show the price performance of SSKN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30 -40

SSKN long term performance overview.The bars show the price performance of SSKN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of SSKN is 1.39 USD. In the past month the price decreased by -19.19%. In the past year, price decreased by -53.13%.

STRATA SKIN SCIENCES INC / SSKN Daily stock chart

SSKN Latest News, Press Relases and Analysis

SSKN Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 25.31 219.65B
ISRG INTUITIVE SURGICAL INC 65.94 201.26B
BSX BOSTON SCIENTIFIC CORP 33.57 146.79B
SYK STRYKER CORP 27.84 140.23B
IDXX IDEXX LABORATORIES INC 58.11 58.51B
BDX BECTON DICKINSON AND CO 13.21 54.59B
EW EDWARDS LIFESCIENCES CORP 32.96 49.16B
RMD RESMED INC 25.34 36.62B
GEHC GE HEALTHCARE TECHNOLOGY 17.48 36.54B
DXCM DEXCOM INC 34.65 25.14B
PODD INSULET CORP 67.61 21.74B
ZBH ZIMMER BIOMET HOLDINGS INC 11.64 18.66B

About SSKN

Company Profile

SSKN logo image STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. The company is headquartered in Horsham, Pennsylvania and currently employs 106 full-time employees. The company went IPO on 2005-10-28. The firm is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.

Company Info

STRATA SKIN SCIENCES INC

5 Walnut Grove Drive, Suite 140

Horsham PENNSYLVANIA 19044 US

CEO: Robert J. Moccia

Employees: 106

SSKN Company Website

SSKN Investor Relations

Phone: 12156193200

STRATA SKIN SCIENCES INC / SSKN FAQ

What does SSKN do?

STRATA Skin Sciences, Inc. is a medical technology company in Dermatology and Plastic Surgery. The company is headquartered in Horsham, Pennsylvania and currently employs 106 full-time employees. The company went IPO on 2005-10-28. The firm is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The firm operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Company’s products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.


Can you provide the latest stock price for STRATA SKIN SCIENCES INC?

The current stock price of SSKN is 1.39 USD. The price decreased by -4.14% in the last trading session.


Does STRATA SKIN SCIENCES INC pay dividends?

SSKN does not pay a dividend.


What is the ChartMill rating of STRATA SKIN SCIENCES INC stock?

SSKN has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


What sector and industry does STRATA SKIN SCIENCES INC belong to?

STRATA SKIN SCIENCES INC (SSKN) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


How many employees does STRATA SKIN SCIENCES INC have?

STRATA SKIN SCIENCES INC (SSKN) currently has 106 employees.


What is the ownership structure of STRATA SKIN SCIENCES INC (SSKN)?

You can find the ownership structure of STRATA SKIN SCIENCES INC (SSKN) on the Ownership tab.


SSKN Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

SSKN Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to SSKN. Both the profitability and financial health of SSKN have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SSKN Financial Highlights

Over the last trailing twelve months SSKN reported a non-GAAP Earnings per Share(EPS) of -2.67. The EPS decreased by -0.38% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -37.56%
ROE -3746.75%
Debt/Equity 49.58
Chartmill High Growth Momentum
EPS Q2Q%32.08%
Sales Q2Q%-21.23%
EPS 1Y (TTM)-0.38%
Revenue 1Y (TTM)0.61%

SSKN Forecast & Estimates

8 analysts have analysed SSKN and the average price target is 8.16 USD. This implies a price increase of 487.05% is expected in the next year compared to the current price of 1.39.

For the next year, analysts expect an EPS growth of 37.76% and a revenue growth -1.34% for SSKN


Analysts
Analysts85
Price Target8.16 (487.05%)
EPS Next Y37.76%
Revenue Next Year-1.34%

SSKN Ownership

Ownership
Inst Owners29.88%
Ins Owners3.09%
Short Float %7.03%
Short Ratio0.05